SCHEMBL19203639

SCHEMBL19203639

CCc1cc2ccc(C(C)(C)C)cc2cn1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 4/20 0.34
NPC1 O15118 2/20 0.34
PDE10A Q9Y233 2/20 0.34
ALDH1A1 P00352 1/20 0.33
HPGD P15428 1/20 0.33
ALOX15 P16050 1/20 0.33
HSD17B10 Q99714 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
MAPT P10636 1/20 0.33
POLB P06746 2/20 0.33
ATM Q13315 2/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
LMNA P02545 1/20 0.33
SCN10A Q9Y5Y9 2/20 0.32
ALOX5AP P20292 1/20 0.32
NR1I2 O75469 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2C19 P33261 1/20 0.32
TDO2 P48775 1/20 0.31
CYP3A4 P08684 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL803215 0.77 CYP1A2 (0.53) RAB9ANPC1PDE10AALDH1A1HPGD
SCHEMBL4548619 0.77 NR1I2 (0.37) RAB9ANPC1ALDH1A1HPGDALOX15
SCHEMBL21920584 0.77 CYP1A2 (0.53) RAB9ANPC1ALDH1A1HPGDALOX15
SCHEMBL10272520 0.75 CYP2A6 (0.42) RAB9ANPC1PDE10ALMNA
SCHEMBL21451242 0.75 CCR9 (0.43) RAB9AALDH1A1HPGDALOX15HSD17B10
SCHEMBL25449345 0.75 PDPK1 (0.52) RAB9ANPC1ALDH1A1HPGDALOX15
SCHEMBL10272932 0.75 CYP2A6 (0.42) PDE10AALDH1A1MAPTL3MBTL1LMNA
SCHEMBL23033200 0.74 PDE10A (0.34) PDE10AALDH1A1HPGDALOX15HSD17B10
SCHEMBL30010382 0.74 ALDH1A1 (0.52) RAB9ANPC1ALDH1A1HPGDALOX15
SCHEMBL348347 0.74 ALDH1A1 (0.52) RAB9ANPC1ALDH1A1HPGDALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017132173-A1 MAYTANSINOID DERIVATIVES, CONJUGATES THEREOF, AND METHODS OF USE REGENERON PHARMACEUTICALS, INC. (US) 2017-08-03 WO disclosed